Anthony Botti in Livingston, New Jersey

Home New Jersey Livingston

Anthony Botti has Hematology/oncology as his primary medical specialty. Their primary office is: 349 E Northfield Rd in Livingston, New Jersey.

They're a part of the: Livingston Subspecialty Group, P.a. medical group which has around 2 members. You can call their office at 973-597-0900 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1982 (around 42 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Anthony Botti Office Phone and Directions

Anthony Botti
Livingston Subspecialty Group, P.a.
349 E Northfield Rd
Livingston, New Jersey 07039
973-597-0900

Patient Ratings
Please rate your experience with Anthony Botti below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 973-597-0900

Enter a starting address:

Healthcare Info for Anthony Botti

Medical School: Sorry, his university is not listed
Graduation Year: 1982
The Primary Medical Specialty for Anthony Botti is listed as: Hematology/oncology
Approximate Years of Experience: 42
PAC (PECOS ID)#: 9830372481
NPI #: 1598787640
NPI Created On: 07/24/2006
NPI Last Updated Listed as: 08/31/2012
Primary Taxonomy Code: 207RH0003X
License Number:
MA045092
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Blue Cross Blue Shield
Humana
Oscar Garden State Insurance Corporation
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Spanish, English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Injection, denosumab, 1 mg
Injection, diphenhydramine hcl, up to 50 mg
Injection, ferric carboxymaltose, 1 mg
Injection, infliximab, excludes biosimilar, 10 mg
Injection, methylprednisolone sodium succinate, up to 40 mg
Injection, vedolizumab, 1 mg
Injection, zoledronic acid, 1 mg
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788455951

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788455955

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788455959

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 797083143

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: KRYSTEXXA

Name of Drug #1: KRYSTEXXA

Open Associated Drug #1: 75987-080-10

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 797083147

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: KRYSTEXXA

Name of Drug #1: KRYSTEXXA

Open Associated Drug #1: 75987-080-10

Payments Total: $13

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 820552493

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hematology

Name of Drug #1: Empaveli

Open Associated Drug #1: 73606-010-01

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008471

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008473

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008475

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008477

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Hematology/oncology Professionals in Livingston

1.
Miguel Conde MD

94 Old Short Hills Rd
Livingston, NJ
Medical Oncology Associates At Saint Barnabas

2.
Stuart Leitner

94 Old Short Hills Rd
Livingston, NJ
Medical Oncology Associates At Saint Barnabas

3.
Stuart Leitner

94 Old Short Hills Rd
Livingston, NJ
Barnabas Health Medical Group Pc

4.
Stephen Abo DO

94 Old Short Hills Rd
Livingston, NJ
Barnabas Health Medical Group Pc

5.
Delia Radovich MD

94 Old Short Hills Rd
Livingston, NJ
Medical Oncology Associates At Saint Barnabas

6.
Delia Radovich MD

94 Old Short Hills Rd
Livingston, NJ
Barnabas Health Medical Group Pc

Providers in Livingston Subspecialty Group, P.a.

1.Anthony Botti

349 E Northfield Rd
Livingston Nj 07039-4806
Livingston Subspecialty Group, P.a.
Hematology/oncology

2.Gigi Diamond

349 E Northfield Rd
Livingston Nj 07039-4806
Livingston Subspecialty Group, P.a.
Infectious Disease

View all 2 members of Livingston Subspecialty Group, P.a. medical group